Skip to content
10-Q

Quarterly Report

BIOTECH ACQUISITION COMPANY

0001213900-22-074335

← back to feed
Filed
Nov 22, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Operating Cash Flow Q3 2022 · Sep 30, 2022 −$385.74K
Operating Cash Flow Q3 2022 · Sep 30, 2021 −$1.15M
Cash And Equivalents Q3 2022 · Sep 30, 2022 $13.15K
Cash And Equivalents Q3 2022 · Dec 31, 2021 $91.41K
Stockholders Equity Q3 2022 · Sep 30, 2022 −$13.12M
Stockholders Equity Q3 2022 · Jun 30, 2022 −$13.37M
Stockholders Equity Q3 2022 · Mar 31, 2022 −$22.47M
Stockholders Equity Q3 2022 · Dec 31, 2021 −$27.17M
Stockholders Equity Q3 2022 · Sep 30, 2021 −$19.88M
Stockholders Equity Q3 2022 · Jun 30, 2021 −$22.81M
Stockholders Equity Q3 2022 · Mar 31, 2021 −$17.74M
Stockholders Equity Q3 2022 · Dec 31, 2020 $20K
Current Liabilities Q3 2022 · Sep 30, 2022 $3.52M
Current Liabilities Q3 2022 · Dec 31, 2021 $313.81K
Total Liabilities Q3 2022 · Sep 30, 2022 $13.22M
Total Liabilities Q3 2022 · Dec 31, 2021 $27.47M
Current Assets Q3 2022 · Sep 30, 2022 $95.25K
Current Assets Q3 2022 · Dec 31, 2021 $299.46K
Total Assets Q3 2022 · Sep 30, 2022 $231.39M
Total Assets Q3 2022 · Dec 31, 2021 $230.32M
Net Income Q3 2022 · Sep 30, 2022 $1.26M
Net Income Q3 2022 · Sep 30, 2022 $15.32M
Net Income Q3 2022 · Jun 30, 2022 $9.38M
Net Income Q3 2022 · Mar 31, 2022 $4.68M
Net Income Q3 2022 · Sep 30, 2021 $2.94M
Net Income Q3 2022 · Sep 30, 2021 $420.98K
Net Income Q3 2022 · Jun 30, 2021 −$5.07M
Net Income Q3 2022 · Mar 31, 2021 $2.55M
Operating Income Q3 2022 · Sep 30, 2022 −$246.57K
Operating Income Q3 2022 · Sep 30, 2022 −$3.41M
Operating Income Q3 2022 · Sep 30, 2021 −$629.85K
Operating Income Q3 2022 · Sep 30, 2021 −$1.24M